Results 121 to 130 of about 109,330 (215)

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

Infectious complications in lupus nephritis treatment: a systematic review and meta-analysis

open access: yes, 2019
Objectives: Infection is an important concern in lupus nephritis treatment, but few studies have focused on this complication. Available data suggest marked variation in occurrence and outcome.
Chan, TM, Thong, KM
core   +1 more source

Immune Repertoire Profiling Reveals Distinct Adaptive Immune Signatures of Dampness ZHENG Across Psoriasis, Rheumatoid Arthritis and Ulcerative Colitis

open access: yesCell Proliferation, EarlyView.
Schematic diagram for the experimental design for adaptome immune repertoire analysing Dampness ZHENG across Psoriasis, Rheumatoid Arthritis and Ulcerative Colitis. ABSTRACT Autoimmune diseases, including psoriasis (Ps), rheumatoid arthritis (RA) and ulcerative colitis (UC), pose significant health burdens worldwide.
Lipeng Tang   +21 more
wiley   +1 more source

Lupus nephritis [PDF]

open access: yesArthritis & Rheumatism, 1962
J, RAITT, H R, HOLMAN
openaire   +2 more sources

Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities

open access: yes, 2023
Ana Neves,1 Luísa Viveiros,2 Veronica Venturelli,3 David A Isenberg4 1Internal Medicine Department, Centro Hospitalar Universitário de São João, Oporto, Portugal; 2Internal Medicine Department, Centro Hospitalar Universitário de Santo António, Oporto ...
Neves A   +3 more
core  

Histopathologic Characterization of Cutaneous Oxalosis Mimicking Calciphylaxis: Diagnostic Pitfalls and Polarized Light Evaluation

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Cutaneous oxalosis is an uncommon manifestation of primary hyperoxalosis, which can often resemble other cutaneous manifestations of end stage renal disease (ESRD), particularly calciphylaxis. We report the case of a 46 year old female with primary hyperoxaluria type one (PH1) believed to be well‐controlled on lumasiran, a small interfering ...
Shrina Patel   +3 more
wiley   +1 more source

Silent nephritis in systemic lupus erythematosus

open access: yes, 2003
Silent lupus nephritis (SLN) was investigated in 42 renal asymptomatic patients and compared with 49 untreated patients with overt lupus nephropathy (OLN).
Zabaleta-Lanz, M.   +5 more
core  

Lupus nephritis susceptibility loci in women with systemic lupus erythematosus

open access: yes, 2014
Lupus nephritis is a manifestation of SLE resulting from glomerular immune complex deposition and inflammation. Lupus nephritis demonstrates familial aggregation and accounts for significant morbidity and mortality.
Chung, Sharon A.   +28 more
core   +1 more source

A rare case of transition to membranous lupus nephritis from diffuse proliferative lupus nephritis [PDF]

open access: yes, 2014
publisher[Abstract] Lupus nephritis is an important complication of systemic lupus erythematosus (SLE) that affects the prognosis. A rare type of lupus nephritis, class V, shows histological findings resembling those of membranous nephropathy. While most
ニシ, ヒトミ   +17 more
core   +1 more source

Biomarkers in lupus nephritis

open access: yes, 2010
A szisztémás lupus erythematosus poliszisztémás autoimmun betegség, egyik legjelentősebb szervi szövődménye a lupus nephritis. A lupus nephritis időbeni, a krónikus szervi érintettség kialakulását megelőző felismerése, a shubok előrejelzése, a korai ...
Boglárka Brúgós, Margit Zeher
core   +1 more source

Home - About - Disclaimer - Privacy